Heidelberg Pharma AG

Director's Dealing • Aug 27, 2012

News Details

Directors’ Dealings | 27 August 2012 18:30

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Company: dievini Hopp BioTech holding GmbH & Co. KG Person performing managerial responsibilities, triggering the disclosure requirement for the legal person Details of the person performing managerial responsibilities Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Subscription obligation Date: 21.08.2012 Price: 3.70 Currency: EUR No. of items: 2100337 Total amount traded: 7771246.90 Place: Ausserbörslich / OTC Explanation for publication: The obligation to subscribe new shares against contribution in kind in the context of the capital increase from authorised capital is attributed to the board members, who at the same time perform management duties for dievini Hopp BioTech holding GmbH & Co. KG Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 27.08.2012 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 15894